AT269137B - Verfahren zur Herstellung neuer Oxazolidinderivate - Google Patents

Verfahren zur Herstellung neuer Oxazolidinderivate

Info

Publication number
AT269137B
AT269137B AT636367A AT636367A AT269137B AT 269137 B AT269137 B AT 269137B AT 636367 A AT636367 A AT 636367A AT 636367 A AT636367 A AT 636367A AT 269137 B AT269137 B AT 269137B
Authority
AT
Austria
Prior art keywords
preparation
oxazolidine derivatives
new
new oxazolidine
derivatives
Prior art date
Application number
AT636367A
Other languages
English (en)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1585465A external-priority patent/CH500216A/de
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AT269137B publication Critical patent/AT269137B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT636367A 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate AT269137B (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH962965A CH484172A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung eines neuen Oxazolidinons
CH1432269A CH490405A (de) 1965-07-09 1965-07-09 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585465A CH500216A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidinderivaten
CH1585565A CH512504A (de) 1965-07-09 1965-11-17 Verfahren zur Herstellung von neuen Oxazolidin-2-on-verbindungen
CH505966A CH507271A (de) 1965-07-09 1966-04-06 Verfahren zur Herstellung von neuen Oxazolidin-2-thion-Verbindungen
CH667066 1966-05-06

Publications (1)

Publication Number Publication Date
AT269137B true AT269137B (de) 1969-03-10

Family

ID=27543759

Family Applications (6)

Application Number Title Priority Date Filing Date
AT587667A AT266832B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen
AT658866A AT266128B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten
AT635867A AT268276B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT587767A AT266129B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von Oxazolidinderivaten und ihren Salzen
AT658766A AT266127B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen
AT636367A AT269137B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate

Family Applications Before (5)

Application Number Title Priority Date Filing Date
AT587667A AT266832B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen
AT658866A AT266128B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten
AT635867A AT268276B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung neuer Oxazolidinderivate
AT587767A AT266129B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von Oxazolidinderivaten und ihren Salzen
AT658766A AT266127B (de) 1965-07-09 1966-07-08 Verfahren zur Herstellung von neuen Oxazolidinderivaten und ihren Salzen

Country Status (11)

Country Link
US (2) US3455946A (de)
AT (6) AT266832B (de)
BE (2) BE683867A (de)
BR (2) BR6681111D0 (de)
CH (4) CH484172A (de)
DE (2) DE1670358A1 (de)
DK (2) DK125893B (de)
FR (4) FR1503574A (de)
GB (2) GB1106594A (de)
NL (2) NL6609639A (de)
SE (2) SE324571B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546231A (en) * 1968-05-03 1970-12-08 Ansul Co Certain 2-(pyridyl-3-thiocarbamoyl-1,3-oxazolidines)
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
IT1109002B (it) * 1977-09-22 1985-12-16 Menarini Sas Derivati del 2 oxazolidone e loro metodi di preparazione
DE3205457A1 (de) * 1982-02-16 1983-08-25 Merck Patent Gmbh, 6100 Darmstadt Oxazolidin-2-one
US4461773A (en) * 1982-09-15 1984-07-24 E. I. Dupont De Nemours And Company P-Oxooxazolidinylbenzene compounds as antibacterial agents
ES523901A0 (es) * 1983-07-06 1985-04-01 Fabr Prod Quimicos Y Farmaceut Un procedimiento para la preparacion de derivados de 3-sulfonamidopiridinas 2 -sustituidas.
JP2008303145A (ja) * 2005-09-22 2008-12-18 Takeda Chem Ind Ltd Grk阻害剤からなる強心薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834968A (en) * 1957-08-28 1960-05-18 Robins Co Inc A H 5-o-alkoxyphenoxymethyl-2-oxazolidones
NL131194C (de) * 1963-07-19

Also Published As

Publication number Publication date
US3455946A (en) 1969-07-15
FR5727M (de) 1968-01-22
BR6681111D0 (pt) 1973-12-26
BE683868A (de) 1967-01-09
AT266128B (de) 1968-11-11
US3480640A (en) 1969-11-25
GB1108538A (en) 1968-04-03
CH512504A (de) 1971-09-15
FR6015M (de) 1968-05-06
FR5728M (de) 1968-01-22
AT266129B (de) 1968-11-11
NL6609640A (de) 1967-01-10
DK126116B (da) 1973-06-12
CH490405A (de) 1970-05-15
FR1503574A (fr) 1967-12-01
NL6609639A (de) 1967-01-10
AT266832B (de) 1968-12-10
DE1670357A1 (de) 1970-10-29
BE683867A (de) 1967-01-09
SE324571B (de) 1970-06-08
AT266127B (de) 1968-11-11
DE1670358A1 (de) 1970-10-29
SE324775B (de) 1970-06-15
CH484172A (de) 1970-01-15
BR6681113D0 (pt) 1973-12-26
CH507271A (de) 1971-05-15
GB1106594A (en) 1968-03-20
AT268276B (de) 1969-02-10
DK125893B (da) 1973-05-21

Similar Documents

Publication Publication Date Title
CH538494A (de) Verfahren zur Herstellung neuer Homopyrimidazol-Derivate
CH460044A (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
AT299463B (de) Verfahren zur Herstellung neuer Isoxazolderivate
CH504426A (de) Verfahren zur Herstellung neuer Bisnorcholanderivate
AT269137B (de) Verfahren zur Herstellung neuer Oxazolidinderivate
CH482724A (de) Verfahren zur Herstellung neuer Aminooxysilane
AT249047B (de) Verfahren zur Herstellung neuer Benzamidobenzanilid-Derivate
CH466282A (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH498120A (de) Verfahren zur Herstellung neuer Indenopyridinderivate
CH513119A (de) Verfahren zur Herstellung neuer Halogencolchicinderivate
CH471076A (de) Verfahren zur Herstellung neuer substituierter Aryloxy-2-hydroxy-3-aminopropane
CH459214A (de) Verfahren zur Herstellung neuer Nitrothiazolverbindungen
CH467801A (de) Verfahren zur Herstellung neuer Benzodiazepinon-Derivate
CH462834A (de) Verfahren zur Herstellung neuer 6-Hydrazino-pyridazin-Derivate
AT279607B (de) Verfahren zur Herstellung neuer Thiadiazolderivate
AT293635B (de) Verfahren zur Herstellung neuer 18-Methyl-5α-H-androstanderivate
AT267775B (de) Verfahren zur Herstellung neuer des-A-5-Oxo-10-hydroxymethylgonadiene
CH474523A (de) Verfahren zur Herstellung neuer 2-Alkyl-3-aryl-3H-4-chinazolone
CH473120A (de) Verfahren zur Herstellung neuer 1-Cycloalkenylpiperidine
CH484154A (de) Verfahren zur Herstellung neuer Thiaminabkömmlinge
AT300806B (de) Verfahren zur Herstellung neuer Piperodin-Derivate
AT260230B (de) Verfahren zur Herstellung neuer Pyrazolderivate
CH507261A (de) Verfahren zur Herstellung neuer Piperazin-Derivate
CH511227A (de) Verfahren zur Herstellung neuer Azetidinolderivate
AT258929B (de) Verfahren zur Herstellung neuer Aziridinderivate